Clinical trial Recruiting at 3 sites Interventional Ages 15 to 65

Characterizing Repetitive Behaviors in OCD and Tic Disorders

Official title: Actimetric and Electrophysiological Analyses of Repetitive Behaviors (Tics and Compulsions)

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT06050369 · Data updated 2026-11-12

This study is testing if special brain activity measurements can help tell the difference between compulsions in OCD and tics in Tourette syndrome to improve treatment options for people aged 15 to 65.

Quick facts

Study typeInterventional
Ages15 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations3 sites (Créteil and 2 other locations)
StatusRecruiting
StartedDecember 28, 2023
Main results expectedDecember 27, 2027
Study endsDecember 27, 2027
Registry record updatedFebruary 12, 2026
Trial IDNCT06050369 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 15 to 65 who have been diagnosed with OCD and/or GTS.

Probably not a fit

Patients with other psychiatric or neurological disorders, or those unable to provide informed consent, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to objectively distinguish between compulsions associated with obsessive-compulsive disorder (OCD) and tics related to Gilles de la Tourette syndrome (GTS) by identifying specific electrophysiological and accelerometric markers. Patients aged 15 to 65 with OCD and/or GTS will be recruited, and their brain activity will be recorded using high-density EEG in a laboratory setting and portable EEG at home while performing tasks. The goal is to enhance treatment selection by providing clear biomarkers for these repetitive behaviors.

Why it matters

Potential benefit: If successful, this study could lead to more accurate diagnoses and tailored treatments for patients with OCD and tic disorders.

How similar studies have gone: While the approach of using electrophysiological markers is promising, it is relatively novel and has not been extensively tested in this specific context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* To be more of 15 years old or less than 65 years old
* To suffer from OCD and/or GTS (depressive, anxious and attention deficit hyperactivity disorder (ADHD) comorbidities are accepted)
* To be registered to the french social security (or something equivalent)
* To give written consent to participate to the research
* To have contraception for women participants (or to not have any sexual activity)

Exclusion Criteria:

* Patients with any other psychiatric disorders than those mentioned in the inclusion criteria
* Patients with any other neurological disorder than GTS
* Patients who are not able to take decisions for themselves
* Pregnant women
* Patients not allowed to get MRI due to contraindication
* Patients not speaking french

Where it's running

  • Hôpital Albert Chenevier
    Créteil, France
    Recruiting
  • Hôpital Henri Mondor
    Créteil, France
    Recruiting
  • Hôpital Pitié Salpêtrière
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Luc MALLET, MD — Assistance Publique - Hôpitaux de Paris
  • Study coordinator: Luc MALLET, MD
  • Email: luc.mallet@inserm.fr
  • Phone: +33157274000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Combined ERP and Habit Reversal Therapy for Tourettic OCD

    This study tests whether a merged Exposure and Response Prevention and Habit Reversal Therapy helps adults with Tourettic OCD more than either therapy alone or basic psychoeducation.

    Recruiting at 2 sites University College London Hospitals · London, London and 1 other locations · NCT07725926

  • Safety and feasibility of a next-generation dome helmet for neuromodulation in OCD

    This study tests whether a new focused ultrasound helmet can safely help people with treatment-refractory OCD see if their symptoms improve.

    Recruiting Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT07704632

  • Emotion-Focused ACT for OCD in Group Therapy

    In adults with OCD, researchers will test whether Emotion-Focused Acceptance and Commitment Therapy (ACT) delivered in a group setting helps reduce OCD symptoms compared with a supportive group.

    Recruiting Goztepe Prof Dr Suleyman Yalcın City Hospital · Istanbul, Istanbul · NCT07622654

  • Personalized closed-loop non-invasive brain stimulation to treat tics in children

    This program will test a personalized, closed-loop transcranial magnetic stimulation (TMS) approach to reduce tics in children and adolescents aged 5 to 18.

    Recruiting Shanghai Children's Medical Center · Shanghai, Shanghai Municipality · NCT07351955

  • Analyzing mental health treatment data from Greenbrook

    This study looks at past treatment data from Greenbrook to see how well different mental health treatments, like NeuroStar TMS and Esketamine, work for people with depression, OCD, and anxiety.

    Recruiting Neuronetics · Malvern, Pennsylvania · NCT06997549

  • Optimizing youth mental health trajectories

    This study is trying to understand how mental health changes in young people aged 9 to 25 over five years to see if we can help prevent problems like depression and ADHD.

    Recruiting Douglas Mental Health University Institute · Montreal, Quebec · NCT06978452

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.